This article examines the evidence for the cardiovascular safety of testosterone replacement therapy in older men with non-specific symptoms and unexplained low testosterone levels.
Written by Prof Robert I McLachlan, FRACP, PhD, AM
Professor Robert McLachlan is a NHMRC Principal Research Fellow at the Hudson Institute of Medical Research is the Director of Andrology Australia and Deputy Director of Endocrinology at Monash Medical Centre. Rob specialises in the area of male reproductive medicine and has made significant contributions to research in endocrinology, infertility and andrology.
Listen to expert interviews.
Click to open in a new tab
PodcastsBrowse the latest monographs from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
